Reversible electroporation for cancer therapy
British Journal of Radiology · 01.03.2025 · 98 (1167) · 313-320
DOI: 10.1093/bjr/tqae231 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Radiology, online erschienen am 23.11.2024. Verfasst von Taha Shiwani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Radiology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7T…. Hauptthemen laut MEDLINE: Electrochemotherapy, Neoplasms, Electroporation, Antineoplastic Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Reversible electroporation (EP) refers to the use of high-voltage electrical pulses on tissues to increase cell membrane permeability. It allows targeted delivery of high concentrations of chemotherapeutic agents including cisplatin and bleomycin, a process known as electrochemotherapy (ECT). It can also be used to deliver toxic concentrations of calcium and gene therapies that stimulate an anti-tumour immune response. ECT was validated for palliative treatment of cutaneous tumours. Evidence to date shows a mean objective response rate of ∼80% in these patients. Regression of non-treated lesions has also been demonstrated, theorized to be from an in situ vaccination effect. Advances in electrode development have also allowed treatment of deep-seated metastatic lesions and primary tumours, with safety demonstrated in vivo. Calcium EP and combination immunotherapy or immunogene electrotransfer is also feasible, but research is limited. Adverse events of ECT are minimal; however, general anaesthesia is often necessary, and improvements in modelling capabilities and electrode design are required to enable sufficient electrical coverage. International collaboration between preclinical researchers, oncologists, and interventionalists is required to identify the most effective combination therapies, to optimize procedural factors, and to expand use, indications and assessment of reversible EP. Registries with standardized data collection methods may facilitate this.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic and Interventional Radiology, St. James's University Hospital, Leeds Teaching Hospitals NHS Trust, Beckett St, Leeds, LS9 7TF, United Kingdom.
ORCID-Profile: Taha Shiwani
Zitieren
APA
Shiwani, T., Singh Dhesi, S., & Wah, T. M. (2025). Reversible electroporation for cancer therapy. British Journal of Radiology, 98(1167), 313-320. https://doi.org/10.1093/bjr/tqae231
Vancouver
Shiwani T, Singh Dhesi S, Wah TM. Reversible electroporation for cancer therapy. British Journal of Radiology. 2025;98(1167):313-320. doi:10.1093/bjr/tqae231
BibTeX
@article{Shiwani2025,
author = {Shiwani, Taha and Singh Dhesi, Simran and Wah, Tze Min},
title = {Reversible electroporation for cancer therapy},
journal = {British Journal of Radiology},
year = {2025},
volume = {98},
number = {1167},
pages = {313--320},
doi = {10.1093/bjr/tqae231}
}
EUVIMED